Facebook Posts
investor.lilly.com/news-releases/news-release-details/lillys-retevmor-selpercatinib-first-targete...
investor.lilly.com
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
Hear from one of the world’s top researchers on what’s new in RET-positive cancer! Click below to RSVP.
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.
happylungsproject.org/finding-the-right-time-to-ask-about-biomarker-testing/![]()
Finding the Right Time to Ask About Biomarker Testing.
#biomarkertesting #RETcancer
Finding the Right Time to Ask About Biomarker Testing - The Happy Lungs Project
happylungsproject.org
Increasingly, cancer care is being approached with precision medicine methods that can offer personalized medical care based on a person’s genes or specific disease. RET cancer testing.
DAVA’S 2nd Hawaii global summit on thoracic malignancies, June 27-July 1. Follow the link to learn more. ![]()
DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies: June 27 - July 1 - The Happy Lungs Project
happylungsproject.org
The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven four-hour sessions with presentations by over 50 key opinion leaders. This summit assembles transl...
We received the following infographic from Ellipses. They have a second gen RET targeted therapy in clinical trials. We do not officially endorse one clinical trial over the other but provide this for informational purposes only. There are several second generation RET targeted therapies in clinical trials. See our website for more clinical trials! happylungsproject.org/current-clinical-trials/
Join Ilana Stromberg and tell your Texas state legislators to pass Senate Bill 989 and House Bill 3188 to make insurers cover biomarker testing.![]()
Ilana, who is a mother to five children, was able to receive life saving precision cancer treatment as a direct result of biomarker testing.![]()
Many insurance companies aren't covering this game-changing testing for everyone who needs it, leaving it unaffordable for many patients. ![]()
66% of doctors who treat cancer report that insurance coverage is a barrier to utilizing this groundbreaking technology. ![]()
Please take a few moments to tell your Texas Representative how critically important access to biomarker testing is for patients and ask them to support and coauthor the bill. Click the link below to write your Texas representative.![]()
tinyurl.com/ym9mv#txlegex#TXBiomarkersr#ACSCANTEXASt#biomarkertestings#hb3188B3188
@drtomoliversontx